ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

LUIS GONZALEZ-INGLES MD

At A Glance: This Prescriber in 2013

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

17,870Medicare Part D Prescriptions Filled, Including Refills

Rank: 66 out of 563

$690K Total Retail Price of All Prescriptions

Rank: 48 out of 563

684 Patients Receiving at Least One Drug in Part D
78% Patients 65 Years and Older
2% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg 81928cdb0ebe162ff75cf405bfacadd396bf3ec84bc467b6f3e612dd63daa776 Average for
this specialty
in Puerto Rico
Lower avg 72b1978e1dcc0b845f89d17d692cfff7aeaf8d8bce70310d8bfc535db2daf62a

Schedule Two
Controlled Substances

2% of this provider’s 684 patients filled at least one prescription for a schedule two drug, compared to an average of 1%.

Schedule Three
Controlled Substances

N/A

Brand Name Drugs

18% of this provider’s prescriptions were for brand-name drugs, compared to an average of 20%.

Prescription Price

$39 was the average price of a prescription from this provider, compared to $35 among peers.

Prescriptions per Patient

26 is the average number of prescriptions (including refills) per patient, compared to an average of 24.


This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

B

A benzodiazepine, or tranquilizer. More » The American Geriatrics Society says these drugs increase the risk of cognitive impairment, delirium, falls and fractures in older adults.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled with Refills Prescriptions
to 65+
Patients Recieving this Drug Category For this Prescriber For All Prescribers in
This Specialty in Puerto Rico
SIMVASTATIN 1,126 891 195 1 1
GLIMEPIRIDE 730 558 115 2 15
GABAPENTIN 696 480 128 3 3
LOSARTAN-HYDROCHLOROTHIAZIDE 653 498 124 4 11
METFORMIN HCL 635 486 105 5 2
OMEPRAZOLE 605 495 107 6 6
AMLODIPINE BESYLATE 540 423 88 7 5
LOSARTAN POTASSIUM 519 424 101 8 4
FENOFIBRATE* 516 380 108 9 30
ATORVASTATIN CALCIUM 472 355 124 10 12
IRBESARTAN 438 373 62 11 34
RANITIDINE HCL 388 287 91 12 7
SYNTHROID 379 306 54 13 10
LEVOTHYROXINE SODIUM 369 321 60 14 8
METOPROLOL SUCCINATE 360 283 75 15 21
CLOPIDOGREL 342 254 68 16 14
HYDROCHLOROTHIAZIDE 330 238 50 17 19
DOXAZOSIN MESYLATE 326 272 52 18 27
LANTUS 305 230 66 19 28
METOPROLOL TARTRATE 283 235 44 20 20
DICLOFENAC SODIUM 263 187 73 21 89
PANTOPRAZOLE SODIUM 248 190 60 22 33
ALENDRONATE SODIUM 230 212 36 23 18
ENALAPRIL MALEATE 219 162 44 24 9
FUROSEMIDE 194 158 43 25 17
BUMETANIDE 183 151 40 26 112
GLIPIZIDE 183 104 29 26 23
TAMSULOSIN HCL 179 147 40 28 36
ATENOLOL 162 126 24 29 13
VERAPAMIL ER 154 132 20 30 42
ISOSORBIDE MONONITRATE ER 154 143 30 30 24
TRAMADOL HCL-ACETAMINOPHEN 154 114 48 30 26
CLOTRIMAZOLE-BETAMETHASONE 133 96 46 33 44
FOSINOPRIL SODIUM 112 82 18 34 102
DIGOX 111 106* 26 35 56
HUMULIN 70-30 109 47 15 36 37
MONTELUKAST SODIUM 107 84 24 37 38
AMLODIPINE BESYLATE-BENAZEPRIL 104 92 16 38 43
IRBESARTAN-HYDROCHLOROTHIAZIDE 101 70 17 39 84
HYDRALAZINE HCL 97 80 25 40 98
LISINOPRIL 97 59 15 40 16
WARFARIN SODIUM 96 71 18 42 47
ZOLPIDEM TARTRATE 94 89* 16 43 32
GLYBURIDE 90 55 11 R 44 91
LEVOFLOXACIN 90 70 80 44 96
FENOFIBRATE* 84 56 20 46 30
EVISTA 78 78 11 47 54
RAMIPRIL 74 41 16 48 51
CARVEDILOL 73 60 20 49 22
SERTRALINE HCL 73 73 14 49 41
CLONAZEPAM 70 54 16 B 51 31
HUMALOG 67 35 19 52 79
METHYLPREDNISOLONE 66 55 51 53 128
DONEPEZIL HCL 64 64 14 54 46
CLONIDINE HCL 61 <11 <11 55 57
MECLIZINE HCL 60 55* 25 56 53
HUMULIN N 59 <11 <11 57 48
OXYBUTYNIN CHLORIDE ER 56 <11 <11 58 170
SULFAMETHOXAZOLE-TRIMETHOPRIM 55 42 52 59 119
INSULIN SYRINGE* 54 40 17 60 50
HUMALOG MIX 50-50 52 <11 <11 61 193
INSULIN SYRINGE* 52 36 13 61 50
LANSOPRAZOLE 52 <11 <11 61 61
TRAMADOL HCL 51 24 12 64 29
About This Data

Prescribing data from Medicare’s prescription drug benefit, known as Part D, was compiled and released by the Centers for Medicare and Medicaid Services, the federal agency that oversees the program. ProPublica combined that data with additional information released by CMS. The data for 2013 includes nearly 1.4 billion prescriptions written by 1.3 million doctors, nurses and other providers. This database lists about 410,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths of these prescriptions went to patients 65 and older; the rest were for disabled patients Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to checkup@propublica.org and we will update your information. If you have other questions about this data, send a note to checkup@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 8, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.